The optimal endoscopic screening interval for detecting early gastric neoplasms - 16/07/14
Abstract |
Background |
The optimal interval between endoscopic examinations for detecting early gastric neoplasms, including gastric adenomas, has not previously been studied.
Objective |
To clarify the optimal interval between endoscopic examinations for the early diagnosis of both gastric cancers and adenomas.
Design |
Retrospective study.
Setting |
University-affiliated tertiary-care hospital, Seoul, Korea.
Patients |
Patients who were treated for gastric neoplasms between January 2008 and August 2013.
Interventions |
Questionnaire survey for interval between the penultimate endoscopy and diagnosis of a gastric neoplasm. A total of 846 patients were divided into 5 groups according to the interval between endoscopic examinations.
Main Outcome Measurements |
The proportion of gastric neoplasms treated with endoscopic submucosal dissection and the proportion of advanced gastric cancers according to the interval between endoscopic examinations.
Results |
In total, 197, 430, and 219 patients were diagnosed with gastric adenoma, early gastric cancer, and advanced gastric cancer, respectively. In multivariate analysis, the proportion of gastric neoplasms treated with endoscopic submucosal dissection was significantly higher in the ≤12 months, 12 to 24 months, and 24 to 36 months endoscopy interval groups than in the no endoscopy within 5 years group (all P < .001). In addition, the proportion of advanced gastric cancers was significantly lower in the ≤12 months and 12 to 24 months endoscopy interval groups than in the no endoscopy within 5 years group (all P < .001).
Limitations |
Retrospective study and recall bias.
Conclusion |
Annual endoscopy cannot facilitate the detection of endoscopically treatable gastric neoplasms compared with biennial or triennial endoscopy. We recommend biennial endoscopic screening for gastric neoplasms in order to increase the proportion of lesions discovered while they are still endoscopically treatable and to reduce the number of lesions that progress to advanced gastric cancer.
Il testo completo di questo articolo è disponibile in PDF.Abbreviations : AGC, EGC, ESD
Mappa
| If you would like to chat with an author of this article, you may contact Dr Lee at sklee@yuhs.ac. |
|
| DISCLOSURE: All authors disclosed no financial relationships relevant to this publication. |
|
| See CME section; p. 311. |
Vol 80 - N° 2
P. 253-259 - agosto 2014 Ritorno al numero
Articolo precedente
- Externally removable stents in the treatment of benign recalcitrant strictures and esophageal perforations in pediatric patients with esophageal atresia
- Michael A. Manfredi, Russell W. Jennings, M. Waseem Anjum, Thomas E. Hamilton, C. Jason Smithers, Jenifer R. Lightdale
- Artificial neural network predicts the need for therapeutic ERCP in patients with suspected choledocholithiasis
- Predrag Jovanovic, Nermin N. Salkic, Enver Zerem
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?